Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo
Materialtyp: Artigo
Språk:engelska
Publicerad: 2018
Länkar:https://doi.org/10.1016/j.ymthe.2018.06.008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!